N, H., SLJ, P., D, B., S, B., R, G., EC, H., . . . MJ, D. (2026). Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study. Journal of the National Comprehensive Cancer Network : JNCCN, 1. https://doi.org/10.6004/jnccn.2026.7011
Chicago Style (17th ed.) CitationN, Heersche, et al. "Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study." Journal of the National Comprehensive Cancer Network : JNCCN 2026: 1. https://doi.org/10.6004/jnccn.2026.7011.
MLA (9th ed.) CitationN, Heersche, et al. "Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study." Journal of the National Comprehensive Cancer Network : JNCCN, 2026, p. 1, https://doi.org/10.6004/jnccn.2026.7011.